ANA5 Funnel Catheter has received the CE Mark certification
Anaconda Biomed is proud to announce that its ANA5 Funnel Catheter has been awarded CE Mark certification, ...
Welcome Dr. Chuck Carignan as our new Chairman
We are pleased to announce the appointment of Dr. Chuck Carignan as Chairman of our company. With deep expertise in clinical practice, ...
Our CEO Trent Reutiman presents Anaconda Biomed at LSI USA ’25 Emerging Medtech Summit in Dana Point, California.
Our CEO Trent Reutiman presents Anaconda Biomed and the ANA Funnel Catheter at LSI USA '25 Emerging Medtech Summit in Dana Point, Calif...
We have enrolled the first U.S. patient in the ATHENA clinical trial evaluating the ANA funnel catheter for the treatment of ischemic stroke.
ATHENA is a global, randomized 327-patient pivotal study evaluating the safety and effectiveness of Anaconda’s proprietary ANA Funnel C...
Anaconda is already an INNOVATIVE SME company
We are super proud to announce that Anaconda is now registered as an INNOVATIVE SME company, valid until January 22nd, 2028.
CDTI invests with Ysios Capital and Asabys Partners in Anaconda Biomed
CDTI Innovación
CDTI Innovación is the public innovation financing entity of the Ministry of Science, Innovation and Universities that...
Trent Reutiman appointed as new CEO
Anaconda Biomed is honored to announce the appointment of Trent Reutiman, a veteran medical technology industry executive, as its new ...
Anaconda is honored to be part of the Scaling Club of the European Innovation Council (EIC)
Anaconda is honored to be among the 72 start-ups from 24 European countries that have been selected to join the Scaling Club of the Eur...
Oli Johnson speaks to Dr. Adnan Siddiqui about Anaconda Biomed’s ANA Funnel Catheter, its enrolment in the ATHENA study and IDE approval.
Speaking to MTI about the limitations of previous devices, coordinate investigator of the ATHENA study Dr. Adnan Siddiqui, Professor of...
Anaconda Biomed Receives IDE Approval to Initiate Enrollment in the ATHENA Study
Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems, has announced that it has received ...